medigraphic.com
ISSN 1561-2996 (Electronic)
ISSN 0864-0289 (Print)

2012, Number 4

<< Back Next >>

Rev Cubana Hematol Inmunol Hemoter 2012; 28 (4)

Regulation of hepcidin and iron homeostasis: progress and prospects

Forrellat-Barrios M, Fernández-Delgado N, Hernández-Ramírez P

Language: Spanish
References: 24
Page: 347-356
PDF size: 94.63 Kb.


ABSTRACT

The study of genetic disorders of iron metabolism, identification of transporters and the discovery of hepcidin- a hormone regulating iron homeostasis- have contributed greatly to increase awareness of this metabolism. Substantially, the vision on diseases related to disorders of iron metabolism has been changed. In the last decade, elements of the pathogenesis of these diseases have not only been clarified, but therapeutic applications of these advances are looming. Thus, there are expectations of a new era based on the treatment of iron homeostasis disorders through hepcidin modulation.


REFERENCES

  1. Ganz T, Nemeth E. The hepcidin-ferroportin system as a therapeutic target in anemias and iron overload disorders. Hematology Am Soc Hematol Educ Program. 2011;2011:538-42.

  2. Fleming RE, Pomka P. Iron overload in human disease. New Engl J Med. 2012 Jan;366(4):348-59.

  3. Ganz T. Hepcidin and iron regulation, 10 years later. Blood. 2011 Apr;117(17):4425-33.

  4. Forrellat-Barrios M, Fernández-Delgado N, Hernández-Ramírez P. Nuevos conocimientos sobre el metabolismo del hierro. Rev Cubana Hematol Inmunol Hemoter. 2005 Dic; 21(3): Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864- 02892005000300003&lng=es

  5. Zhang AS, Enns CA. Molecular mechanisms of normal iron homeostasis. Hematology Am Soc Educ Program. 2009:207-14.

  6. Muñoz M, García-Erce JA, Remacha AF. Disorders of iron metabolism. Part 1: Molecular basis of iron homeostasis. J Clin Pathol. 2011 Apr;64(4):281-6.

  7. Ramey G, Deschemin JC, Durel B, Canonne-Hergaux F, Nicolas G, Vaulont S. Hepcidin targets ferroportin for degradation in hepatocytes. Haematologica. 2010 Mar;95(3):501-4.

  8. Pietrangelo A. Hepcidin in human iron disorders: therapeutics implications. J Hepathol. 2011 Jan;54(1):173-81.

  9. Flanagan JM, Truksa J, Peng H, Lee P, Beutler E. In vivo imaging of hepcidina promoter stimulaton by iron and inflammation. Blood Cell Mol Dis. 2007 May-Jun; 38(3):253-7.

  10. Babitt JL, Huang FW, Wrighting DM, Xia Y, Sidis Y, Samad TA, et al. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidina expression. Nat Genet. 2006 May;38(5):531-9.

  11. Meynard D, Kautz L, Darnaud V, Canonne-Hergaux F, Coppin H, Roth MP. Lack of the bone morphogenetic protein BMP6 induces iron overload. Nat Genet. 2009 Apr;41(4):478-81.

  12. Andriopoulos B Jr, Corradini E, Xia Y, Faasse SA, Chen S, Grgurevic L, et al. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat Genet. 2009 Apr;41(4):482-7.

  13. Silvestri L, Pagani A, Nai A, De Domenico I, Kaplan J, Camaschella C. The serine protease matriptase 2 (TMPRSS6) inhibits hepcidina activation by cleaving membrane hemojuvelin. Cell Metab. 2006 Dec;8(6):502-11.

  14. Goswani T, Andrews NC. Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for Mammalian iron sensing. J Biol Chem. 2006 Sep;281(39):28494-8.

  15. Wrighting DM, Andrews NC. Interleukin-6 induces hepcidina expression through STAT3. Blood 2006 Nov;108(9):3204-9.

  16. Babitt JL, Huang FW, Xia Y, Sidis Y, Andrews NC, Lin HY. Modulation of bone morphogenetic proteins signaling in vivo regulates systremic iron balance. J CLin Invest. 2007 Jul;117(7):1933-9.

  17. Finberg KE. Unraveling mechanisms regulating systemic iron homeostasis. Hematology. Am Soc Hematol Educ Program. 2011;2011:532-7.

  18. Vecchi C, Montosi G, Zhang K, Lamberti I, Duncan SA, Kaufman RJ, et al. ER stress controls iron metabolism through induction of hepcidina. Science. 2009 Aug;325(5942):877-80.

  19. Ganz T, Nemeth E. Hepcidin and disorders of iron metabolism. Annu Rev Med. 2011;62:347-60.

  20. Silvestri L, Pagani A, Camascella C. Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis. Blood. 2008 Jan;111(2):924-31.

  21. Lakhal S, Schodel J, Towsend AR, Pugh CW, Ratcliff PJ, Mole DR. Regulation of type II transmembrane serin proteinase TMPRSS6 by hypoxia-inducible factors: a new link between hypoxia signalling and iron homeostasis. J Biol Chem. 2011 Feb;286(6):4090-7.

  22. Zanitsky J, Young B, Wang HJ, Westerman M, Olbina G, Nemeth E, et al. Hepcidin a potential novel biomarker for iron status in chronic kidney disease. Clin J Am Soc Nephrol. 2009 Jun;4(6):1051-6.

  23. Hentze MW, Muckenthaler MV, Galy B, Camaschella C. Two to tango:regulation of mammalian iron metabolism. Cell. 2010 Jul;142(1):24-38.

  24. Castoldi M, Vujic Spasic M, Altamura S, Elmén J, Lindow M, Kiss J, et al. The liver-especific microRNA miR-122 controls systemic iron homeostasis in mice. J Clin Invest. 2011;121(4):1386-96.




2020     |     www.medigraphic.com